rash at injection site of tirzepatide Tirzepatide-Induced Reaction Injection Site Itching and Swelling
Description
The information provided reflects publicly available clinical data and general guidance as of April 2026
Start every eating window with easily digestible protein
Serious adverse events remain rare in clinical populations, with no unexpected safety signals emerging in long-term observational data
If overdose or intolerance requires protocol changes, PlexusDx adjusts your regimen at no additional charge during your current commitment tier
The patient's stool initially tested positive for Campylobacter
